Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Julien Edeline

46PUBLICATIONS
129CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Predictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

Sort by Publication Date:
|Apr 29, 2026
Impact of Child Pugh B Stage for the Treatment of Advanced HCC.

|Mar 02, 2026
Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naïve Advanced Hepatocellular Carcinoma: Long-Term Follow-up of the Open-Label, Phase II KEYNOTE-224 Study.

Richard S Finn, Masatoshi Kudo, Ivan Borbath

|Feb 27, 2026
Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study.

Stephen L Chan, Thomas Yau, Robin K Kelley

|Feb 16, 2026
Machine learning models classifiers enable a strong prediction of radioembolization-induced liver disease, and define a new bilirubin threshold for selection of patients.

Itzel Rivera, Heloïse Bourien, Ewan Morel-Corlu

|Dec 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and priorities.

Jesus M Banales, Pedro M Rodrigues, Silvia Affò

|Oct 06, 2025
Management of biliary tract cancers in elderly patients: a French multicenter retrospective study (PRONOBIL-ACABi).

Marine Valery, Julien Edeline, Julie Henriques

Pageof 8

Frequent Collaborators

8 joint publications

Juan W Valle

5 joint publications

David Malka

4 joint publications

Anthony Turpin

4 joint publications

Mairéad G McNamara

4 joint publications

David Tougeron

4 joint publications

Boris Campillo-Gimenez

4 joint publications

Arndt Vogel

4 joint publications

Heinz-Josef Klümpen

3 joint publications

Cédric Coulouarn

3 joint publications

Richard S Finn

Frequent Collaborators

8 joint publications

Juan W Valle

5 joint publications

David Malka

4 joint publications

Anthony Turpin

4 joint publications

Mairéad G McNamara

Top Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on : Sep 30, 2021

7.2K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on : Sep 12, 2019

9.6K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

1.3K
See more related videos

Top Related Videos

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on : Sep 30, 2021

7.2K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on : Sep 12, 2019

9.6K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on : May 24, 2024

1.3K
See more related videos